Electronic nose versus gas chromatography – mass spectrometry for diagnostic discrimination of advanced hepatocellular carcinoma by volatolomic analysis

• by Moustafa S. Mahmoud, Mohamed S. Mshaly, Hend N. Abdel-Reheim, Mamdouh M. Shawki, Radwa A. Meshref, Ehab I. Mohamed

• May 11, 2026

2026 ASCO Breast Cancer Highlights: BWEL

Harold Burstein, MD, PhD, and Jennifer A. Ligibel, MD discuss new research from the Breast Cancer Weight Loss (BWEL) trial, as well as recommendations for lifestyle, diet and GLP1 agonists.

• October 15, 2026

• 1 min

2026 ASCO Breast Cancer Highlights: SENOMAC

Harold Burstein, MD, PhD, and Laura S. Dominici, MD, FACS, discuss highlights from the SENOMAC trial which sheds light on whether some patients with early breast cancer and limited lymph node involvement can safely avoid additional axillary surgery.

• October 15, 2026

• 1 min

Personalized Breast Cancer Screening: Moving Beyond Age-Based Algorithms

Breast cancer screening has traditionally been organized around two principal variables: when mammography should begin and how frequently it should be performed.

• by

• October 16, 2026

• 7 min